Cargando…

Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma

Little is known about the impact of adrenocortical carcinoma (ACC) on health-related quality of life (HRQoL), and no disease-specific questionnaire exists. This qualitative study aimed to identify relevant domains of HRQoL for patients with ACC. In 2 focus group interviews, we discussed concerns reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Steenaard, Rebecca V, Kremers, Marjolein N T, Michon, Laura A, Zijlstra, Myrte, Haak, Harm R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174051/
https://www.ncbi.nlm.nih.gov/pubmed/32342024
http://dx.doi.org/10.1210/jendso/bvaa040
_version_ 1783524558868840448
author Steenaard, Rebecca V
Kremers, Marjolein N T
Michon, Laura A
Zijlstra, Myrte
Haak, Harm R
author_facet Steenaard, Rebecca V
Kremers, Marjolein N T
Michon, Laura A
Zijlstra, Myrte
Haak, Harm R
author_sort Steenaard, Rebecca V
collection PubMed
description Little is known about the impact of adrenocortical carcinoma (ACC) on health-related quality of life (HRQoL), and no disease-specific questionnaire exists. This qualitative study aimed to identify relevant domains of HRQoL for patients with ACC. In 2 focus group interviews, we discussed concerns regarding living with ACC and its treatments. The first group consisted of 6 patients on mitotane therapy and their partners or relatives, the second group of 4 patients after surgery alone and their partners. Inductive qualitative content analysis was used to analyze the interviews. We identified 4 domains related to HRQoL in patients with ACC, namely physical complaints, mental consequences, social consequences, and functional limitations. For example, physical complaints included symptoms of the disease and side effects of mitotane therapy; mental consequences included feeling insecure and living from scan to scan; and functional limitations included daily activities and mobility. We further found that patients’ experiences with the health care system and health care professionals and partner perspectives influence HRQoL. In conclusion, ACC has a large impact on HRQoL in 4 domains. These results can be used to improve communication about HRQoL issues. We will use our findings to generate a disease-specific questionnaire to measure HRQoL in patients with ACC.
format Online
Article
Text
id pubmed-7174051
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71740512020-04-27 Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma Steenaard, Rebecca V Kremers, Marjolein N T Michon, Laura A Zijlstra, Myrte Haak, Harm R J Endocr Soc Research Article Little is known about the impact of adrenocortical carcinoma (ACC) on health-related quality of life (HRQoL), and no disease-specific questionnaire exists. This qualitative study aimed to identify relevant domains of HRQoL for patients with ACC. In 2 focus group interviews, we discussed concerns regarding living with ACC and its treatments. The first group consisted of 6 patients on mitotane therapy and their partners or relatives, the second group of 4 patients after surgery alone and their partners. Inductive qualitative content analysis was used to analyze the interviews. We identified 4 domains related to HRQoL in patients with ACC, namely physical complaints, mental consequences, social consequences, and functional limitations. For example, physical complaints included symptoms of the disease and side effects of mitotane therapy; mental consequences included feeling insecure and living from scan to scan; and functional limitations included daily activities and mobility. We further found that patients’ experiences with the health care system and health care professionals and partner perspectives influence HRQoL. In conclusion, ACC has a large impact on HRQoL in 4 domains. These results can be used to improve communication about HRQoL issues. We will use our findings to generate a disease-specific questionnaire to measure HRQoL in patients with ACC. Oxford University Press 2020-04-01 /pmc/articles/PMC7174051/ /pubmed/32342024 http://dx.doi.org/10.1210/jendso/bvaa040 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Article
Steenaard, Rebecca V
Kremers, Marjolein N T
Michon, Laura A
Zijlstra, Myrte
Haak, Harm R
Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma
title Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma
title_full Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma
title_fullStr Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma
title_full_unstemmed Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma
title_short Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma
title_sort patient and partner perspectives on health-related quality of life in adrenocortical carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174051/
https://www.ncbi.nlm.nih.gov/pubmed/32342024
http://dx.doi.org/10.1210/jendso/bvaa040
work_keys_str_mv AT steenaardrebeccav patientandpartnerperspectivesonhealthrelatedqualityoflifeinadrenocorticalcarcinoma
AT kremersmarjoleinnt patientandpartnerperspectivesonhealthrelatedqualityoflifeinadrenocorticalcarcinoma
AT michonlauraa patientandpartnerperspectivesonhealthrelatedqualityoflifeinadrenocorticalcarcinoma
AT zijlstramyrte patientandpartnerperspectivesonhealthrelatedqualityoflifeinadrenocorticalcarcinoma
AT haakharmr patientandpartnerperspectivesonhealthrelatedqualityoflifeinadrenocorticalcarcinoma